CDC COVID-19 Response Team. Coronavirus disease 2019 in children—United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:422-426. doi:10.15585/mmwr.mm6914e4
2.
ChaoJYDerespinaKRHeroldBC, et al. Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 (COVID-19) at a tertiary care medical center in New York City. J Pediatr. Published online May 11, 2020. doi:10.1016/j.jpeds.2020.05.006
3.
Centers for Disease Control and Prevention. Emergency preparedness and response. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). Published May 14, 2020. Accessed May 16, 2020. https://emergency.cdc.gov/han/2020/han00432.asp
McCrindleBWRowleyAHNewburgerJW, et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927-e999. doi:10.1161/CIR.0000000000000484
8.
VerdoniLMazzaAGervasoniA, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395:1771-1778. doi:10.1016/S0140-6736(20)31103-X
9.
RiphagenSGomezXGonzalez-MartinezCWilkinsonNTheocharisP.Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607-1608. doi:10.1016/S0140-6736(20)31094-1
10.
JonesVMillsMSuarezD, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020;10:537-540. doi:10.1542/hpeds.2020-0123
11.
FeldLBelferJKabraR, et al. A case series of the 2019 novel coronavirus (SARS-CoV-2) in three febrile infants in New York. Pediatrics. 2020:e20201056. doi:10.1542/peds.2020-1056